Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new app called VestAid, which aims to help people recover from dizziness related to mild traumatic brain injuries (mTBI) or inner ear problems more quickly than traditional physical therapy exercises. The trial will involve several centers and will compare how well the app works against the standard care usually provided to patients experiencing these issues.
To participate, individuals must be between 18 and 60 years old and have experienced dizziness due to a concussion or inner ear problem within the last 30 days. They should also be able to see and read English clearly, access the internet at home, and have mild neck pain (if any). Participants will use the VestAid app and may find it a convenient way to manage their dizziness symptoms from the comfort of their own home. It's important to note that the trial is not yet recruiting participants, so more information will be available soon.
Gender
ALL
Eligibility criteria
- Inclusion:
- • Snellen visual acuity (corrected) greater than 20/40
- • No more than 25dB hearing loss at 500,1000, 2000, and 4000 Hz
- • Ability to detect 4.31 using Semmes-Weinstein monofilament at the lower extremity
- • At least 40 degrees of neck yaw motion with only mild to moderate pain (6 or under on 0-10 numeric pain scale)
- • Internet access at home
- • No significant residual from past musculoskeletal or neuromuscular conditions
- • Ability ambulates unassisted
- • Diagnosed with a concussion or inner ear problem the last 30 days
- • Between 18-60 years of age
- • Can read and understand English
- • Has complaints of dizziness
- Exclusion criteria:
- • Greater then 30 days since diagnosis of concussion/mTBI or inner ear problem
- • No access to internet at home
- • Younger than 18 years of age or older than 60 years of age
- • Cannot read or understand English
- • No complaints of dizziness and/or balance deficits
- • Have significant neuropathy
- • Cannot see tablet clearly at 1 meter
- • Neck pain \>5 on a 10-point pain scale.
About Bluehalo
BlueHalo is a forward-thinking clinical trial sponsor dedicated to advancing innovative therapeutics through rigorous research and development. With a focus on enhancing patient outcomes, BlueHalo collaborates with healthcare professionals and research institutions to design and execute clinical trials that adhere to the highest standards of scientific integrity and ethical practice. Leveraging cutting-edge technologies and a patient-centric approach, BlueHalo aims to accelerate the discovery of novel treatments while ensuring safety and efficacy throughout the clinical trial process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported